JPH02249540A - Device for joining together blood vessels - Google Patents
Device for joining together blood vesselsInfo
- Publication number
- JPH02249540A JPH02249540A JP8971409A JP7140989A JPH02249540A JP H02249540 A JPH02249540 A JP H02249540A JP 8971409 A JP8971409 A JP 8971409A JP 7140989 A JP7140989 A JP 7140989A JP H02249540 A JPH02249540 A JP H02249540A
- Authority
- JP
- Japan
- Prior art keywords
- blood vessel
- joining
- adhesive
- surgical
- blood vessels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 97
- 238000005304 joining Methods 0.000 title claims abstract description 49
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000001356 surgical procedure Methods 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 10
- 229920002050 silicone resin Polymers 0.000 claims abstract description 5
- 239000003106 tissue adhesive Substances 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 abstract description 12
- 239000000853 adhesive Substances 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 9
- 229920005989 resin Polymers 0.000 abstract description 6
- 239000011347 resin Substances 0.000 abstract description 6
- 229920001059 synthetic polymer Polymers 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- -1 fluororesin Polymers 0.000 abstract description 4
- 239000004743 Polypropylene Substances 0.000 abstract description 2
- 229920013716 polyethylene resin Polymers 0.000 abstract description 2
- 229920001155 polypropylene Polymers 0.000 abstract description 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000009958 sewing Methods 0.000 abstract 1
- 230000003872 anastomosis Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003894 surgical glue Substances 0.000 description 6
- 229920001228 polyisocyanate Polymers 0.000 description 5
- 239000005056 polyisocyanate Substances 0.000 description 5
- 210000004088 microvessel Anatomy 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- 206010053648 Vascular occlusion Diseases 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 208000021331 vascular occlusion disease Diseases 0.000 description 2
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004821 Contact adhesive Substances 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- UTGQNNCQYDRXCH-UHFFFAOYSA-N N,N'-diphenyl-1,4-phenylenediamine Chemical compound C=1C=C(NC=2C=CC=CC=2)C=CC=1NC1=CC=CC=C1 UTGQNNCQYDRXCH-UHFFFAOYSA-N 0.000 description 1
- KEQFTVQCIQJIQW-UHFFFAOYSA-N N-Phenyl-2-naphthylamine Chemical compound C=1C=C2C=CC=CC2=CC=1NC1=CC=CC=C1 KEQFTVQCIQJIQW-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000003576 central nervous system agent Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 125000006551 perfluoro alkylene group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Landscapes
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、血管接合用器具に関する。さらに詳しくは、
外科用接着剤を用いて血管の接合操作を行う際、手術操
作を円滑に行うために用いる器具に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a blood vessel coaptation device. For more details,
The present invention relates to an instrument used to smoothly perform a surgical operation when joining blood vessels using surgical adhesive.
[従来の技術]
従来、血管の接合は、縫合糸を用いた縫合方法(”外科
MOOK−4−縫合と吻合” 金属出版、1978)お
よび外科用接着剤を用いた接合方法(特開昭11i2−
148GeB号公報)等によって行われていた。[Prior art] Conventionally, blood vessels have been joined by a suturing method using suture thread ("Surgical MOOK-4 - Suturing and Anastomosis", Metal Publishing, 1978) and a joining method using surgical adhesive (Japanese Patent Application Laid-Open No. 11-12-2011). −
148GeB Publication) etc.
[発明が解決しようとする課題]
血管の縫合・吻合は、術中の血管損傷修復や悪性腫瘍の
拡大根治手術に伴う血管切除・移植等−般外科において
当然必要とされる手術手技である。[Problems to be Solved by the Invention] Suturing and anastomosis of blood vessels is a surgical technique that is naturally required in general surgery, such as repair of vascular damage during surgery and vascular resection and transplantation accompanying radical surgery for expansion of malignant tumors.
太い血管については、縫合糸による縫合も手術手技上さ
ほど問題がみられないものの、微小血管(一般に外径3
■以下の血管)の接合については、ミクロ外科手術の領
域になることから、6〜40倍の拡大率を有する双眼顕
微鏡を用いる特殊な技術を必要とし、多大の時間と困難
さが伴うのが実吠である。このため、縫合糸を用いない
外科用接着剤による接合方法の検討が近年活発に行われ
てきた。しかしながら、外科用接着剤による微小血管の
接合については、手術時間の短縮や組織との良好な接着
性は得られるものの、手術時に血管が潰れた形状で接着
接合を行うため、接合部の血管内断面が小さくなり、血
管閉塞の問題点が手術手技の面で指摘されてきた。Regarding large blood vessels, suturing with suture threads does not pose much of a problem in terms of surgical technique;
■The following blood vessels) are involved in microsurgery and require special techniques using a binocular microscope with a magnification of 6 to 40 times, which is time consuming and difficult. It's true. For this reason, studies have been actively conducted in recent years on bonding methods using surgical adhesives that do not use sutures. However, although the joining of microvessels using surgical adhesives shortens the surgical time and provides good adhesion to the tissue, the adhesive joining is performed with the blood vessel in a collapsed shape during surgery, so the inside of the blood vessel at the joint is As the cross-section becomes smaller, the problem of vascular occlusion has been pointed out in terms of surgical techniques.
[課題を解決するための手段]
上記問題点に鑑みて本発明者らは、血管とりわけ微小血
管の接合手術を行う際の閉塞を防止するため、接合部の
血管内断面を保持し、確実な血管の接合と共に手術時間
の短縮が行える血管接合用器具を見い出すべく鋭意検討
した結果、本発明に到達した。[Means for Solving the Problems] In view of the above-mentioned problems, the present inventors have developed a method to maintain the intravascular cross section of the junction and ensure a reliable As a result of extensive research to find a device for joining blood vessels that can shorten surgical time, we have arrived at the present invention.
すなわち、本発明はウレタンプレポリマーと接着しない
物質で製造され、かつ外科用接着剤を用いた血管接合手
術を行う際、血管内にその一部を挿入することが可能な
、テーパー状の棒であることを特徴とする血管接合用器
具である。That is, the present invention is a tapered rod that is made of a material that does not adhere to urethane prepolymer and that can be partially inserted into a blood vessel when performing blood vessel joining surgery using surgical adhesive. This is a blood vessel joining device characterized by the following.
本発明のウレタンプレポリマーと接着しない物質として
は、シリコーン樹脂、フッ素樹脂、ポリエチレン樹脂、
ポリプロピレン樹脂等の合成重合体が挙げられる。これ
らの樹脂は、単独でもまた他の樹脂との配合物でもかま
わない。これらの中で好ましいものは、シリコーン樹脂
およびフッ素樹脂であり、特に好ましいものは、フッ素
樹脂である。Examples of substances that do not adhere to the urethane prepolymer of the present invention include silicone resin, fluororesin, polyethylene resin,
Examples include synthetic polymers such as polypropylene resin. These resins may be used alone or in combination with other resins. Among these, silicone resins and fluororesins are preferred, and fluororesins are particularly preferred.
本発明の血管接合用器具の製造方法としては、上記の合
成重合体単独で作る方法や、他の素材(金属、プラスチ
ック、セラミック等)で作られた器具に上記の合成重合
体をコーティングまたはライニングする方法等が挙げら
れる。The method of manufacturing the blood vessel joining device of the present invention includes a method of manufacturing the above-mentioned synthetic polymer alone, and a method of manufacturing the device made of other materials (metal, plastic, ceramic, etc.) with the above-mentioned synthetic polymer. Examples include a method to do so.
本発明の血管接合用器具の形状は、棒状でその一部を血
管内に挿入するためテーパー状になっている必要がある
。先端は、円錐状に尖っていても、また丸く切断されて
いてもよい。例えば、本血管接合用器具が硬い素材で造
られている場合には、先端が尖っていると血管壁を傷つ
け易くなるので、丸く切断されているか半球状になって
いる必要がある。一方、軟らかい素材で作成されている
場合には、先端が尖っていた方が取扱上好ましい。The shape of the blood vessel joining device of the present invention is rod-like, and in order to insert a portion into the blood vessel, it must be tapered. The tip may be conically pointed or rounded. For example, if the blood vessel joining device is made of a hard material, the tip should be rounded or hemispherical, since a sharp tip will easily damage the blood vessel wall. On the other hand, if it is made of a soft material, it is better to have a sharp tip for handling.
また血管内に挿入することから、先端部は対象となる血
管内径よりも小さいことが必要であり、もう一方の端の
外径は血管内径よりも大きいことが必要である。血管に
挿入する方の外径は、通常3II11以下、好ましくは
1mm以下である。もう一方の端の外径は、通常3m1
以上、好ましくは5〜10mmである。Furthermore, since it is inserted into a blood vessel, the distal end needs to be smaller than the inner diameter of the target blood vessel, and the outer diameter of the other end needs to be larger than the inner diameter of the blood vessel. The outer diameter of the side inserted into the blood vessel is usually 3II11 or less, preferably 1 mm or less. The outside diameter of the other end is usually 3m1
Above, preferably 5 to 10 mm.
本発明において用いられる、外科用接着剤としては、■
特開昭82−148G88号公報記載のポリイソシアネ
ート類(トリレンジインシアネート(TDI)、ジフェ
ニルメタンジイソシアネートCMDI)、p−フェニレ
ンジイソシアネート(PPD I)Wの芳香族ポリイソ
シアネート、脂肪族ポリイソシアネート、脂環式ポリイ
ソシアネート等)と親水性ポリエーテルポリオール類(
少なくとも2個の活性水素を有する化合物(エチレング
リコール、プロピレングリコール等)とエチレンオキシ
ド及び必要により他のアルキレンオキシドとの付加物)
とのNGO末端親水性ウレタンプレポリマー、■特願昭
63−52918号公報記載の含フツ素ポリイソシアネ
ート類(一般式: OCN・Rt ’ NGOおよび一
般式: OCN * CIItRrCHg 11NCO
(ただしRtは炭素数1〜20のパーフルオロアルキレ
ン基であり、1g以上のエーテル結合を含有するものも
含む)等)と親水性ポリエーテルポリオール類(少な(
とも2個の活性水素を有する化合物(エチレングリコー
ル、プロピレングリコール等)とエチレンオキシド及び
必要により他のアルキレンオキシドとの付加物)との含
フッ素系NGO末端親水性ウレタンプレポリマー等が挙
げられる。これらのウレタンプレポリマーの中で、好ま
しいものは含フッ素系NGO末端親水性ウレタンプレポ
リマーである。The surgical adhesive used in the present invention includes:
Aromatic polyisocyanates, aliphatic polyisocyanates, alicyclic polyisocyanates (tolylene diisocyanate (TDI), diphenylmethane diisocyanate CMDI), p-phenylene diisocyanate (PPD I) W described in JP-A-82-148G88 polyisocyanates, etc.) and hydrophilic polyether polyols (
Adducts of compounds having at least two active hydrogens (ethylene glycol, propylene glycol, etc.) with ethylene oxide and other alkylene oxides if necessary)
NGO-terminated hydrophilic urethane prepolymers, ■Fluorine-containing polyisocyanates described in Japanese Patent Application No. 63-52918 (general formula: OCN・Rt' NGO and general formula: OCN * CIItRrCHg 11NCO
(However, Rt is a perfluoroalkylene group having 1 to 20 carbon atoms, including those containing 1 g or more of ether bond), hydrophilic polyether polyols (small
Examples include fluorine-containing NGO-terminated hydrophilic urethane prepolymers of compounds having two active hydrogens (ethylene glycol, propylene glycol, etc.) and adducts of ethylene oxide and, if necessary, other alkylene oxides. Among these urethane prepolymers, preferred is a fluorine-containing NGO-terminated hydrophilic urethane prepolymer.
なお外科用接着剤には、必要に応じて生理活性を有する
薬物(中枢神経用薬、アレルギー用薬、循環器官用薬、
呼吸器官用薬、消化器官用薬、ホルモン剤、代謝性医薬
品、抗悪性腫瘍剤、抗生物質製剤、化学療法剤等)、充
填剤(カーボンブラック、ベンガラ、ケイ酸カルシウム
、ケイ酸ナトリウム、酸化チタン、アクリル系樹脂粉末
、各種セラミック粉末等)、軟化剤[ジブチルフタレー
) (DBP)、ジオクチルフタレー) (DOP)、
トリクレジルホスフェート(TCP)、 )リブトキシ
エチルホスフェート、その他各種エステル類等J1
安定剤(トリメチルジヒドロキノン、フェニル−β−ナ
フチルアミン、p−インプロポキシジフェニルアミン、
ジフェニル−p−フェニレンジアミン等)等を配合する
ことができる。これらの配合量は、外科用接着剤に対し
て通常0〜20重量%、好ましくは0〜5重量%である
。Surgical adhesives may contain physiologically active drugs (central nervous system drugs, allergy drugs, circulatory organ drugs,
Respiratory organ drugs, digestive organ drugs, hormones, metabolic drugs, antineoplastic agents, antibiotic preparations, chemotherapy drugs, etc.), fillers (carbon black, red iron, calcium silicate, sodium silicate, titanium oxide) , acrylic resin powder, various ceramic powders, etc.), softeners [dibutyl phthalate] (DBP), dioctyl phthalate) (DOP),
Tricresyl phosphate (TCP), ) ribtoxyethyl phosphate, and other various esters J1
Stabilizers (trimethyldihydroquinone, phenyl-β-naphthylamine, p-impropoxydiphenylamine,
diphenyl-p-phenylenediamine, etc.) can be blended. The amount of these compounds is usually 0 to 20% by weight, preferably 0 to 5% by weight, based on the surgical adhesive.
本発明の血管接合用器具を用いた血管の接合手術、例え
ば血管の端端吻合手術の場合、以下のように行う。これ
を図面(第3図)に従って説明する。第3図において1
は血管、2は本発明の血管接合用器具、3は外科用接着
剤、4は外科用接着剤の切断面、5は血管断面を示す。In the case of blood vessel joining surgery using the blood vessel joining instrument of the present invention, for example, end-to-end blood vessel anastomosis surgery, it is performed as follows. This will be explained according to the drawing (FIG. 3). In Figure 3, 1
2 is a blood vessel, 2 is a blood vessel joining instrument of the present invention, 3 is a surgical adhesive, 4 is a cut surface of the surgical adhesive, and 5 is a cross section of a blood vessel.
■片方の血管l内に本発明の血管接合用器具2を挿入す
る。血管接合用器具の最大径は、血管の内径より大きい
ものを選択する必要がある。これによって、血管接合用
器具の一部だけの挿入となり、残りは血管の外にあるこ
とになる(第3図(a))。(2) Insert the blood vessel joining device 2 of the present invention into one blood vessel l. The maximum diameter of the blood vessel joining device must be selected to be larger than the inner diameter of the blood vessel. This results in the insertion of only a portion of the blood vessel coaptation device, with the remainder remaining outside the blood vessel (FIG. 3(a)).
■血管接合用器具2を挿入した部分を中心に、血管1お
よび血管接合用器具全体に外科用接着剤3を塗布する(
第3図(b))。■Apply surgical adhesive 3 to the entire blood vessel 1 and the blood vessel splicing device, focusing on the area where the blood vessel splicing device 2 has been inserted (
Figure 3(b)).
■外科用接着剤3が固化した後、血管接合用器具2を抜
き取ることで、血管1の端が外科用接着剤3によって固
定された状態となる。(2) After the surgical adhesive 3 has solidified, the blood vessel joining instrument 2 is removed, so that the end of the blood vessel 1 is fixed by the surgical adhesive 3.
■固化した外科用接着剤3を血管lごとメス、ハ゛サミ
等によって切断し、血管の断面を露出した状態にする(
第3図(C))。■ Cut the solidified surgical adhesive 3 with a scalpel, scissors, etc. to expose the cross section of the blood vessel (
Figure 3 (C)).
■もう一方の血管lについても同様の操作を行う。■Perform the same operation for the other blood vessel l.
■血管!の断面同士が接触するように、固化した外科用
接着剤3を相合わせ、その周囲を外科用接着剤の塗布、
および/または縫合糸によって吻合を終了する(第3図
(d))。■Vessels! The solidified surgical adhesive 3 is brought together so that the cross sections of the two sides are in contact with each other, and the surgical adhesive is applied around the solidified surgical adhesive 3.
and/or terminate the anastomosis with sutures (FIG. 3(d)).
[実施例コ
以下、実施例および比較例により本発明を更に説明する
が、本発明はこれに限定されるものではない。以下にお
いて、EOはエチレンオキシド、POはプロピレンオキ
シドを示す。実施例および比較例において使用した外科
用接着剤は次の通りである。[Examples] The present invention will be further explained below with reference to Examples and Comparative Examples, but the present invention is not limited thereto. In the following, EO represents ethylene oxide and PO represents propylene oxide. The surgical adhesives used in Examples and Comparative Examples are as follows.
外科用接着剤AI:
OCR@C■2(CF2)40H211NCOと減圧上
脱水したポリエーテルポリオール(EO/POランダム
共重合体、平均分子量3 、000. オキシエチレ
ン含有量80%)とを80℃の温度で8時間反応させて
、ウレタンプレポリマー系外科用接着剤を得た(NGO
含有率2゜5%)。Surgical adhesive AI: OCR@C■2 (CF2) 40H211NCO and polyether polyol (EO/PO random copolymer, average molecular weight 3,000, oxyethylene content 80%) dehydrated under reduced pressure were heated at 80°C. After reacting at temperature for 8 hours, a urethane prepolymer surgical adhesive was obtained (NGO
content 2°5%).
実施例1
ツブW樹jl(四フブ化エチレン・パーフロロアルキル
ビニルエーテル共重合体)の棒を円錐状(低面の直径:
51m% 長さ: 150mm)に加工して、本発
明の血管接合用器具を得た。Example 1 A rod of WJJ (tetrafubuted ethylene/perfluoroalkyl vinyl ether copolymer) was shaped into a cone (diameter of the lower surface:
51m% Length: 150mm) to obtain a blood vessel joining device of the present invention.
成犬の動脈(外径約1.5av)に鉗子をかけ、−時的
に結索して切断し、端端吻合手術を行った。−方の血管
内に上記の血管接合用器具を挿入した。The adult dog's artery (outer diameter approximately 1.5 av) was placed with forceps, temporarily tied and cut, and an end-to-end anastomosis was performed. The above blood vessel joining device was inserted into the − side of the blood vessel.
器具の先端部は血管内に入り、後半部は外部に出た状態
となり、血管接合用器具は血管に対して栓をした形とし
た。血管の端(挿入部)の周囲に対して外科用接着剤A
+を塗布した。8分後、外科用接着剤が硬化した後、血
管接合用器具を抜取り、血管を含めて外科用接着剤をメ
スで切断した。接着剤の断面の中に円形の血管断面が保
持された、ドーナツ状の接着剤末端が得られた。もう片
方の血管に対しても同様の処置を行った。接着剤部分を
持ち、両方の血管断面同士を接触させ、外科用接着剤を
周囲に再度塗布して血管の接合を行った。The distal end of the instrument entered the blood vessel, and the rear half extended outside, so that the blood vessel joining instrument was in the form of a plug against the blood vessel. Surgical adhesive A around the end of the blood vessel (insertion site)
+ was applied. Eight minutes later, after the surgical adhesive had hardened, the blood vessel joining instrument was removed, and the surgical adhesive, including the blood vessel, was cut with a scalpel. A doughnut-shaped adhesive end was obtained with a circular vessel cross-section retained within the adhesive cross-section. Similar treatment was performed on the other blood vessel. Holding the adhesive part, both vessel sections were brought into contact and surgical adhesive was reapplied around the circumference to join the vessels.
5分後血流を再開したが、なんら出血も見られず、血流
の流れもスムーズで良好な回復を示した。Five minutes later, the blood flow was resumed, but no bleeding was observed, and the blood flow was smooth, indicating a good recovery.
実施例2
ステンレスで作製され、先端部をカットした円錐状の針
(低面の直径=7關、先端部の直径:0.5關、長さ:
15hm)にシリコーン樹脂をコーティングして本発
明の血管接合用器具を得た。Example 2 A conical needle made of stainless steel with a cut tip (diameter of bottom surface = 7 mm, diameter of tip: 0.5 mm, length:
15hm) was coated with silicone resin to obtain a blood vessel joining device of the present invention.
成犬の動脈(外径約3−諺)に鉗子をかけ、−時的に結
索し、自家静脈を用いる端側吻合手術を行った。移植血
管である自家静脈は、二尖弁を有し血液は一定方向のみ
流れることから移植方向を確認して行った。移植血管の
一端に上記の血管接合用器具を挿入した。器具の先端部
は血管内に入り、後半部は外部に出た状態となり、血管
接合用器具は血管に対して栓をした形とした。血管の端
(挿入部)の周囲に対して外科用接着剤A+を塗布した
。The adult dog's artery (approximately 3 mm outer diameter) was placed with forceps, temporarily tied, and an end-to-side anastomosis using autologous veins was performed. Since the autologous vein used as the transplanted blood vessel has a bicuspid valve and blood flows only in a certain direction, the direction of the transplantation was confirmed. The above blood vessel joining device was inserted into one end of the transplanted blood vessel. The distal end of the instrument entered the blood vessel, and the rear half extended outside, so that the blood vessel joining instrument was in the form of a plug against the blood vessel. Surgical adhesive A+ was applied around the end of the blood vessel (insertion site).
外科用接着剤が硬化した後、血管接合用器具を抜取り、
血管を含めて外科用接着剤をメスで切断した。接着剤の
断面の中に円形の血管断面が保持された、ドーナツ状の
接着剤末端が得られた。血管を含めて外科用接着剤をメ
スで切断した。接着剤の断面の中に円形の血管断面があ
るドーナツ状の末端が得られた。次いで宿主血管の吻合
部に対しても同様の操作を行い、 硬化機血管側壁に楕
円形の開口部が得られるように切断した。接着剤部分を
持ち、両方の血管断面同士を接触させ、仮縫合(Sta
y 5uture)を2針かけた後、外科用接着剤を周
囲に再度塗布して血管の接合を行った。5分後血流を再
開したが、なんら出血も見られず、血流の流れもスムー
ズで良好な回復を示した。After the surgical adhesive has hardened, the blood vessel joining instrument is removed.
The surgical adhesive, including the blood vessels, was cut with a scalpel. A doughnut-shaped adhesive end was obtained with a circular vessel cross-section retained within the adhesive cross-section. The surgical adhesive, including the blood vessels, was cut with a scalpel. A donut-shaped end was obtained with a circular vessel cross-section within the adhesive cross-section. Next, the same operation was performed on the anastomotic site of the host blood vessel, and the anastomotic site was cut so that an oval opening was obtained in the side wall of the sclerosing vessel. Holding the adhesive part, touch the cross sections of both blood vessels and temporarily suture (Sta
After applying two stitches of 5 y 5 ture, surgical adhesive was applied again to the surrounding area to join the blood vessels. Five minutes later, the blood flow was resumed, but no bleeding was observed, and the blood flow was smooth, indicating a good recovery.
比較例1
成犬の動脈(外径的1.5mm)にかんしをかけ、−時
的に結紮し切断し、端端吻合手術を行った。両方の血管
切断面同士を接触させ、仮縫合(staySuture
)を2針かけた後、外科用接着剤A1を周囲に塗布して
血管の接合を行った。5分後血流を再開したが、接合部
における血管断面が充分保持されていなかったため、良
好な接着性能を示したものの血流の流れはスムーズで無
く、手術後閉塞した。Comparative Example 1 An adult dog's artery (outer diameter: 1.5 mm) was combed, temporarily ligated and cut, and end-to-end anastomosis was performed. Bring the cut surfaces of both blood vessels into contact with each other, and apply a temporary suture (staySture).
), and then surgical adhesive A1 was applied to the surrounding area to join the blood vessels. After 5 minutes, the blood flow was resumed, but because the cross section of the blood vessel at the joint was not sufficiently maintained, although good adhesion performance was exhibited, the blood flow was not smooth, resulting in post-operative occlusion.
[発明の効果]
本発明の血管接合用器具は、外科用接着剤の育している
接着性能を充分に生かすための血管手術用器具として優
れている。すなわち、■本面管接合用器具を血管内に挿
入することにより血管内断面が充分に保持される。■外
科用接着剤を用いることで、取り扱い易い形状の切断断
面が得−られる。[Effects of the Invention] The blood vessel joining instrument of the present invention is excellent as a blood vessel surgical instrument for making full use of the adhesive properties of surgical adhesives. That is, (1) the intravascular cross section is sufficiently maintained by inserting the main plane tube joining instrument into the blood vessel; - By using surgical adhesive, a cut cross section with an easy-to-handle shape can be obtained.
■本面管接合用器具は、テーパー吠の形状を取っている
ことから一つの大きさで殆ど大部分の太さの血管に適用
することが可能である。以上の事から、従来、非常に難
しいとされてきた微小血管の縫合も、本発明の血管接合
用器具を用いることで、接合時における血管の閉塞を回
避することが可能となり、安全にかつ短時間に手術を行
うことが可能となった。また本器具を用いた接合方法は
、微小血管ばかりでなく、内径を保持することが必要な
管状の生体組織一般(例えば静脈を含めた血管全般、リ
ンパ管、気管、消化管等)の接合についてもを効であり
、医療全般にわたって高信頼性と高性能を付与する効果
がみられる。■Since the main tube joining device has a tapered shape, it can be applied to blood vessels of almost all diameters with one size. Based on the above, by using the blood vessel joining instrument of the present invention, suturing of microvessels, which has conventionally been considered extremely difficult, can be done safely and quickly by avoiding occlusion of blood vessels during joining. It became possible to perform the surgery on time. In addition, the joining method using this device is suitable for joining not only microvessels but also general tubular living tissues that require maintaining the inner diameter (e.g. blood vessels in general including veins, lymphatic vessels, trachea, gastrointestinal tract, etc.). It is also effective in providing high reliability and high performance in all medical fields.
外科用接着剤による血管縫合は、縫合糸による従来の方
法と比較して、接合の確実性や手術時間の短縮また接合
部からの止血等著しい効果が得られた。しかし、微小血
管の接合は、外科用接着剤を用いても幾つかの問題があ
った。とりわけ、接合すべき血管が潰れた状態で取り扱
うため、接合のための操作が非常に難しいこと、また接
合に際して血管内断面が充分保持されず血管閉塞の問題
も指摘されてきた。本発明の血管接合用器具によれば、
この様な問題点が解消される。Blood vessel suturing using surgical adhesive has been shown to have significant effects, such as more reliable joining, shorter surgical time, and hemostasis from the joint, compared to conventional methods using sutures. However, there are some problems in joining microvessels even when using surgical adhesives. In particular, it has been pointed out that the operation for joining is extremely difficult because the blood vessels to be joined are handled in a collapsed state, and that the internal cross section of the blood vessel is not sufficiently maintained during joining, resulting in the problem of vascular occlusion. According to the blood vessel joining device of the present invention,
Such problems are solved.
第1図は、ウレタンプレポリマーと接着しない物質(フ
ッソ樹脂)で製造された、本発明の血管接合用器具を示
す斜視図である。
第2図は、ステンレス製の器具の先端部に、ウレタンプ
レポリマーと接着しない物質(フッソ樹脂)をコーティ
ングした本発明の血管接合用器具を示す斜視図である。
第31図は、本発明の血管接合用器具を成犬の頚動脈に
用いたときの使用方法を示す説明図である。
l:血管、2:血管接合用器具、3:外科用接着剤、4
:外科用接着剤の断面、5:血管断面。
図面の浄書(内容に変更なし)
第1図
、、、−、−5II−I
第2図
一閣一:−−−E
図
第3図
手
続
補
正
1ゴ
1庁長官
古
田
文
毅
殿
1゜
平成1年特許願第71409号
発明の名称
血管接合用器具
1正をする者
自発
補正により増加する請求項の数FIG. 1 is a perspective view showing a blood vessel joining device of the present invention made of a urethane prepolymer and a non-adhesive material (fluorocarbon resin). FIG. 2 is a perspective view showing a blood vessel joining device of the present invention in which the distal end of the stainless steel device is coated with a substance (fluorocarbon resin) that does not adhere to urethane prepolymer. FIG. 31 is an explanatory diagram showing how to use the blood vessel joining device of the present invention on the carotid artery of an adult dog. l: Blood vessel, 2: Blood vessel joining instrument, 3: Surgical adhesive, 4
: Cross section of surgical adhesive, 5: Cross section of blood vessel. Engraving of the drawings (no changes to the contents) Figure 1, -, -5II-I Figure 2 Ikkakuichi: ---E Figure 3 Procedural amendments 1 Go 1 Agency Director Furuta Fumiki 1゜Heisei 1 year patent application No. 71409 Name of the invention Blood vessel joining device 1 Number of claims increased due to voluntary amendment by the person making the correction
Claims (1)
、かつ外科用接着剤を用いた血管接合手術を行う際、血
管内にその一部を挿入することが可能な、テーパー状の
棒であることを特徴とする血管接合用器具。 2、ウレタンプレポリマーと接着しない物質が、シリコ
ーン樹脂および/またはフッ素樹脂である請求項1記載
の血管接合用器具。 3、外科手術用器具が、ウレタンプレポリマーと接着し
ない物質を器具にコーティングまたはライニングするか
、またはウレタンプレポリマーと接着しない物質自体で
製造された器具である請求項1または2記載の血管接合
用器具。[Claims] 1. A tapered material that is made of a material that does not adhere to the urethane prepolymer and that can be partially inserted into a blood vessel when performing blood vessel joining surgery using surgical adhesive. A device for connecting blood vessels, characterized in that it is a rod. 2. The blood vessel joining device according to claim 1, wherein the substance that does not adhere to the urethane prepolymer is a silicone resin and/or a fluororesin. 3. The surgical instrument for blood vessel joining according to claim 1 or 2, wherein the instrument is coated or lined with a substance that does not adhere to the urethane prepolymer, or is manufactured from a substance itself that does not adhere to the urethane prepolymer. utensils.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8971409A JPH02249540A (en) | 1989-03-23 | 1989-03-23 | Device for joining together blood vessels |
EP19900303222 EP0390481B1 (en) | 1989-03-23 | 1990-03-27 | Surgical adhesive sheet |
US08/127,477 US5457141A (en) | 1989-03-23 | 1993-09-28 | Surgical adhesive sheet, surgical instruments and methods of using the same |
US08/335,341 US5486547A (en) | 1989-03-23 | 1994-11-03 | Surgical adhesive sheet, surgical instruments and methods of using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8971409A JPH02249540A (en) | 1989-03-23 | 1989-03-23 | Device for joining together blood vessels |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02249540A true JPH02249540A (en) | 1990-10-05 |
Family
ID=13459688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8971409A Pending JPH02249540A (en) | 1989-03-23 | 1989-03-23 | Device for joining together blood vessels |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02249540A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03505682A (en) * | 1989-04-18 | 1991-12-12 | カンシン ニコライ ニコラエビチ | Rod for suture surgical instruments |
-
1989
- 1989-03-23 JP JP8971409A patent/JPH02249540A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03505682A (en) * | 1989-04-18 | 1991-12-12 | カンシン ニコライ ニコラエビチ | Rod for suture surgical instruments |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6443957B1 (en) | Suture-free clamp and sealing port and methods of use | |
US6251116B1 (en) | Device for interconnecting vessels in a patient | |
US8216259B2 (en) | Compositions and methods for joining non-conjoined lumens | |
US7892247B2 (en) | Devices and methods for interconnecting vessels | |
US5222971A (en) | Temporary stent and methods for use and manufacture | |
US6165185A (en) | Method for interconnecting vessels in a patient | |
US20010032023A1 (en) | Tunneling device | |
US7892246B2 (en) | Devices and methods for interconnecting conduits and closing openings in tissue | |
US20040073282A1 (en) | Distally-narrowed vascular grafts and methods of using same for making artery-to-vein and artery-to-artery connections | |
JP2005131389A (en) | Graft coupling apparatus and method of using same | |
JPH02249540A (en) | Device for joining together blood vessels | |
Fabiani et al. | Use of glue without graft replacement for type A dissections: a new surgical technique | |
Yamamoto et al. | Clinical application of a nonpenetrating microvascular stapling device for vascularized free tissue transfer | |
JPH11335A (en) | Blood vessel anastomosis aid | |
US20050165428A1 (en) | Absorable surgical structure | |
JP7074643B2 (en) | The main body of the anastomosis aid and the anastomosis aid | |
Graver et al. | Use of the variable-length intraluminal sutureless graft | |
US20130030324A1 (en) | Malignancy removal with tissue adhesive secured structure | |
US20230310001A1 (en) | Anastomotic coupling device | |
JP2009118927A (en) | Medical device for tissue anastomosis | |
Ross | Creation of native arteriovenous fistulas with interrupted anastomoses using a self-closing clip device-one clinic's experience | |
CN116492028A (en) | Artificial blood vessel implantation device | |
Allen et al. | Rectocolectomy with anal conservation in inflammatory colitis. | |
JPS63109852A (en) | Blood vessel connector | |
JPH02249557A (en) | Device for surgical operation |